182 related articles for article (PubMed ID: 8989060)
21. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
Grove A; Lipworth BJ
Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798
[TBL] [Abstract][Full Text] [Related]
22. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.
Gongora HC; Wisniewski AF; Tattersfield AE
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):626-9. PubMed ID: 1679981
[TBL] [Abstract][Full Text] [Related]
23. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
24. One week treatment with salmeterol does not prevent early and late asthmatic responses and sputum eosinophilia induced by allergen challenge in asthmatics.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Di Franco A; Giannini D; Taccola M; Vagaggini B; Paggiaro PL
Pulm Pharmacol Ther; 2004; 17(3):147-53. PubMed ID: 15123224
[TBL] [Abstract][Full Text] [Related]
25. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
[TBL] [Abstract][Full Text] [Related]
26. A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion.
Taylor IK; O'Shaughnessy KM; Choudry NB; Adachi M; Palmer JB; Fuller RW
J Allergy Clin Immunol; 1992 Feb; 89(2):575-83. PubMed ID: 1346794
[TBL] [Abstract][Full Text] [Related]
27. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics.
Grutters JC; Brinkman L; Aslander MM; van den Bosch JM; Koenderman L; Lammers JW
Eur Respir J; 1999 Oct; 14(4):915-22. PubMed ID: 10573242
[TBL] [Abstract][Full Text] [Related]
28. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
Gong H; Linn WS; Shamoo DA; Anderson KR; Nugent CA; Clark KW; Lin AE
Chest; 1996 Nov; 110(5):1229-35. PubMed ID: 8915226
[TBL] [Abstract][Full Text] [Related]
29. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Lipworth BJ; Dempsey OJ; Aziz I
Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
[TBL] [Abstract][Full Text] [Related]
30. Partial inhibition of the early and late asthmatic response by a single dose of salmeterol.
Weersink EJ; Aalbers R; Koëter GH; Kauffman HF; De Monchy JG; Postma DS
Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1262-7. PubMed ID: 7952550
[TBL] [Abstract][Full Text] [Related]
31. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment.
Drotar DE; Davis EE; Cockcroft DW
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563
[TBL] [Abstract][Full Text] [Related]
32. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.
Derom EY; Pauwels RA; Van der Straeten ME
J Allergy Clin Immunol; 1992 Apr; 89(4):811-5. PubMed ID: 1560164
[TBL] [Abstract][Full Text] [Related]
33. Regular inhaled salbutamol and airway responsiveness to allergen.
Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
[TBL] [Abstract][Full Text] [Related]
34. Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists.
van der Woude HJ; Aalbers R
Eur Respir J; 2001 Aug; 18(2):269-71. PubMed ID: 11529283
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
36. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
37. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
[TBL] [Abstract][Full Text] [Related]
38. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma.
Kraft M; Wenzel SE; Bettinger CM; Martin RJ
Chest; 1997 May; 111(5):1249-54. PubMed ID: 9149578
[TBL] [Abstract][Full Text] [Related]
39. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
[TBL] [Abstract][Full Text] [Related]
40. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
Woolcock A; Lundback B; Ringdal N; Jacques LA
Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
